OUR TEAM
Cara Caasi Singh-Founder/CEO
Cara has been in healthcare since 2011 and worked in various positions in clinical research since 2018.
Her work caring for cancer patients during her time at Cambridge University Hospitals ignited her passion to transition in clinical research and contribute to make a difference in developing better treatments for patients and alleviate the burden of disease, witnessing breakthrough results and development of positive outcomes fueled her commitment to evolve in the clinical research space, engaging in multi therapy research practice.
Achievements:
* UK NIHR Cancer Research Awardee 2020
* Led the establishment and management of 1st commercial psychedelic trial-focused facility in Europe
*She has led a multitude of clinical trial portfolios within NHS and SMOs, which put her team in the Top 3 recruiter status for several trials with some surpassing recruitment targets
*Pioneered the initiation of critical systems for site operationalisation and safety- CTMS, SOPs, feasibility process and study set up framework
* Managed and mentored staff at the site operations level and developed high-performing teams
Expertise:
- Clinical Operations
- Leadership and Clinical Excellence
- Patient Engagement and Recruitment
- Business Development
- Regulatory and Sponsor Affairs
- Training and Education
Previous Affiliations:
- Cambridge University Hospitals NHS Foundation Trust- Cambridge Cancer Trials Centre, Panthera Biopartners, Clerkenwell Health
Alexandra Diaz-Co-Founder/COO
Alexandra has been in the healthcare industry since 2001. Her research journey started in 2009 in various positions with equally valuable experiences that led to her current role as COO at Ascend Clinical Research.
Her passion in research is anchored on her belief that she is helping to make a difference.
She said: “I may not see the results of these clinical trials I am involved with but knowing that I am a part of something great that will better the health of the next generation, I can say I have done my part!”
Achievements:
* NIHR GCP Facilitator
*Led multi - therapeutic research portfolios in the NHS and commercial SMO
Expertise:
- Clinical Operational Compliance
- Oncology Research
- Driving Regulatory Adherence
- Cross-Functional Collaboration in EMEA region
- Leadership and Excellence
Previous Affiliations:
- Imperial College NHS Trust
- Royal Marsden NHS Trust
- Panthera Biopartners
- Impact Futures
Dr. David Torku-Principal Investigator
A dually registered medical doctor and pharmacist
* Expert in medical affairs and pharmacovigilance
* Multi- therapy leadership as Principal investigator/Sub-Investigator in the following therapy areas:
· Cardio metabolism (Lipids, LP(a)).
· Respiratory (COPD).
· Immunology (COVID-19 monoclonal antibody).
· Vaccine (COVID-19, RSV).
· Oncology (Metastatic breast cancer, Lung cancer).
· Gastroenterology (NAFLD, NASH, IBD).
· CNS (Migraine, MS).
· Rheumatology (Osteoarthritis, Rheumatoid arthritis).
· Women’s Health (Menopause)
· Dermatology (Atopic dermatitis, Psoriasis)
· Substance misuse (Alcohol use disorder)
* Expert Ethics Committee Member
